Less than a month after retiring as CEO of Eli Lilly and Co., Sidney Taurel has joined BioCrossroads Inc.'s board of directors. BioCrossroads, an Indianapolis-based group that promotes development of life sciences businesses, made the announcement this morning.
Taurel is continuing as chairman of Lilly, the Indianapolis-based drugmaker, until the end of this year. He also sits on the boards of IBM Corp. and McGraw-Hill Cos. Inc. and serves on the board of overseers of Columbia Business School.
Taurel is a trustee at the Indianapolis Museum of Art, a board member of the Indianapolis Tennis Championships and a member of the U.S. Advisory Committee for Trade Policy and Negotiations.
Taurel spent 37 years at Lilly, nearly 10 as CEO. He was succeeded April 1 by John C. Lechleiter.